Some think that it might be time to add a new class of drugs to the existing categories.
You are here
P&T® Journal contents for May 2005
Health Care & Law
Analyzing patients’ prescription and medical claims from a managed care organization, the authors evaluate the risk of heart failure after TZD therapy.
Drug Class Review
Proton Pump Inhibitors in the Management of Patients with Acid-Peptic Disorders: A Managed Care Perspective
Drs. McCarthy and Caspi describe the benefits and risks of intravenous and oral PPIs and the considerations regarding their inclusion on formularies.
Using Technology to Expand Services: An Application of Satellite Distribution in the Pharmaceutical Market
The authors describe the use of telemedicine and telepharmacy to provide drug delivery to low-income, underserved segments of the population.
Consensus Panel Recommendations for the Assessment and Management of Breakthrough Pain Part 1 Assessment
The authors illustrate their discussion of cancer-related and non–cancer-related pain in a pertinent case study with an emphasis on pharmacological management.